| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000232151.5 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019143296 |
Resistant |
| ENSG00000232151.5 |
Gefitinib |
Skin cutaneous melanoma |
0.038261781 |
Sensitive |
| ENSG00000232151.5 |
Gefitinib |
Thyroid carcinoma |
0.049057961 |
Sensitive |
